CIK 0001448431
- Non-accelerated filer
- Smaller reporting company
OptimizeRx Corp
Sign in to watch- Ticker
- OPRX
- Exchange
- Nasdaq
- Industry
- Services-Business Services, NEC
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 261265381
- Phone
- +1 248-651-6558
- Business address
- 260 CHARLES STREET, SUITE 302, WALTHAM, MA, 02453
- 4 Exercise or conversion Director acquired 334 shares (option exercise)
- 4 Open-market buy General Counsel and CCO bought 1,000 shares at $15.75 ($15,750)
- 4 Open-market buy Director bought 6,000 shares at $16.45 ($98,723)
- 4 Open-market buy CEO bought 16,100 shares at an average $15.59 ($251,005)
- 4/A Insider Changes in Ownership
- 4 Open-market buy CCO bought 3,200 shares at $15.66 ($50,112)
- 4 Open-market buy Director bought 500 shares at $15.91 ($7,955)
- 4 Open-market buy CFO/COO bought 3,000 shares at $15.43 ($46,290)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 23 · 444 filings